Amphotericin B Lipid Complex Shortage
Last Updated: April 28, 2024
Status: Current
Products Affected - Description
-
- Abelcet intravenous suspension for injection, Leadiant Biosciences, 100 mg, 20 mL vial, NDC 57665-0101-41
Reason for the Shortage
-
- Leadiant Biosciences has Abelcet suspension for injection on back order due to a manufacturing issue.
- Amphotericin B liposomal formulations are not affected by the shortage.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Leadiant Biosciences has Abelcet 100 mg/20 mL vials on back order and the company cannot estimate a release date.
Updated
Updated April 28, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created August 5, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.